Study type: Human research · Status: Verified against declared source
Role and Impact of Cerebrolysin for Ischemic Stroke Care
2022
Study scale: Stroke is still a significant health problem that affects millions of people worldwide, as it is the second-leading cause of death and the third-leading cause of disability.
Abstract only: Open source record
Product or molecular entity relationships
- Cerebrolysin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Stroke is still a significant health problem that affects millions of people worldwide, as it is the second-leading cause of death and the third-leading cause of disability.
Methods
The study of Muresanu et al., CARS 1, showed a positive influence of Cerebrolysin on both functional and overall outcomes in early stroke rehabilitation.
Scale or participants
Stroke is still a significant health problem that affects millions of people worldwide, as it is the second-leading cause of death and the third-leading cause of disability.
Key findings
Stroke is still a significant health problem that affects millions of people worldwide, as it is the second-leading cause of death and the third-leading cause of disability.
Limitations and uncertainty
The innovative concepts of neuroprotection and neurorecovery have been actively researched in many clinical studies in the past.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.